255 related articles for article (PubMed ID: 16210875)
1. Cyclooxygenase-2 inhibition prevents colorectal cancer: from the bench to the bed side.
Samoha S; Arber N
Oncology; 2005; 69 Suppl 1():33-7. PubMed ID: 16210875
[TBL] [Abstract][Full Text] [Related]
2. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.
Gupta RA; Dubois RN
Nat Rev Cancer; 2001 Oct; 1(1):11-21. PubMed ID: 11900248
[TBL] [Abstract][Full Text] [Related]
3. Use of NSAIDs for the chemoprevention of colorectal cancer.
Herendeen JM; Lindley C
Ann Pharmacother; 2003 Nov; 37(11):1664-74. PubMed ID: 14565811
[TBL] [Abstract][Full Text] [Related]
4. [Cyclooxygenase(COX)-2-inhibition in the prevention and treatment of colorectal carcinoma].
Tuynman JB; Hulscher JB; Steller EP; van Lanschot JJ; Richel DJ
Ned Tijdschr Geneeskd; 2003 Nov; 147(45):2207-12. PubMed ID: 14640057
[TBL] [Abstract][Full Text] [Related]
5. COX-2 inhibition as a tool to treat and prevent colorectal cancer.
Tuynman JB; Peppelenbosch MP; Richel DJ
Crit Rev Oncol Hematol; 2004 Nov; 52(2):81-101. PubMed ID: 15501074
[TBL] [Abstract][Full Text] [Related]
6. COX-2, NSAIDs and human neoplasia. Part I: Colorectal neoplasms.
Nasir A; Fernandez PM; Chughtai OR; Kaiser HE
In Vivo; 2002; 16(6):501-9. PubMed ID: 12494894
[TBL] [Abstract][Full Text] [Related]
7. COX-2: a molecular target for colorectal cancer prevention.
Brown JR; DuBois RN
J Clin Oncol; 2005 Apr; 23(12):2840-55. PubMed ID: 15837998
[TBL] [Abstract][Full Text] [Related]
8. An introduction to aspirin, NSAids, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part II.
Moyad MA
Semin Urol Oncol; 2001 Nov; 19(4):306-16. PubMed ID: 11769882
[TBL] [Abstract][Full Text] [Related]
9. Chemoprevention of colorectal cancer: ready for routine use?
Arber N; Levin B
Recent Results Cancer Res; 2005; 166():213-30. PubMed ID: 15648192
[TBL] [Abstract][Full Text] [Related]
10. Cancer prevention: a new era beyond cyclooxygenase-2.
Rigas B; Kashfi K
J Pharmacol Exp Ther; 2005 Jul; 314(1):1-8. PubMed ID: 15805430
[TBL] [Abstract][Full Text] [Related]
11. NSAIDs to prevent colorectal cancer: a question of sensitivity.
Elder DJ; Paraskeva C
Gastroenterology; 1997 Dec; 113(6):1999-2003. PubMed ID: 9394741
[No Abstract] [Full Text] [Related]
12. Role of cyclooxygenase-2 in pathogenesis and prevention of colorectal cancer.
Hahn E; Kraus S; Arber N
Dig Dis; 2010; 28(4-5):585-9. PubMed ID: 21088406
[TBL] [Abstract][Full Text] [Related]
13. Prevention of colorectal cancer through the use of COX-2 selective inhibitors.
Peek RM
Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S50-6. PubMed ID: 15309515
[TBL] [Abstract][Full Text] [Related]
14. [Clinical application of cyclooxygenase-2 inhibitors].
Dzielska-Olczak M; Olczak S
Pol Merkur Lekarski; 2001 Jun; 10(60):480-2. PubMed ID: 11503270
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2 inhibition in colorectal cancer: boom or bust?
Sanborn R; Blanke CD
Semin Oncol; 2005 Feb; 32(1):69-75. PubMed ID: 15726508
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms for the prevention of gastrointestinal cancer: the role of prostaglandin E2.
Backlund MG; Mann JR; Dubois RN
Oncology; 2005; 69 Suppl 1():28-32. PubMed ID: 16210874
[TBL] [Abstract][Full Text] [Related]
17. [Prevention of colorectal cancer: acetylsalicyclic acid and cyclo-oxygenase-2 inhibitors are only partially effective].
Kleibeuker JH; de Vries EG
Ned Tijdschr Geneeskd; 2003 Nov; 147(45):2203-7. PubMed ID: 14640056
[TBL] [Abstract][Full Text] [Related]
18. COX-2-specific inhibition: implications for clinical practice.
Pascucci RA
J Am Osteopath Assoc; 1999 Nov; 99(11 Suppl):S18-22. PubMed ID: 10643177
[TBL] [Abstract][Full Text] [Related]
19. [Cyclooxygenase 2 inhibitors and colorectal cancer].
Bernardeau-Mozer M; Chaussade S
Bull Cancer; 2004 May; 91 Suppl 2():S89-98. PubMed ID: 15899632
[TBL] [Abstract][Full Text] [Related]
20. Chemoprevention of colorectal cancer through inhibition of cyclooxygenase-2.
Dannenberg AJ; Zakim D
Semin Oncol; 1999 Oct; 26(5):499-504. PubMed ID: 10528897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]